vimarsana.com

Card image cap

Objective To evaluate the effect of protracted low dose, low dose rate exposure to ionising radiation on the risk of cancer.

Design Multinational cohort study.

Setting Cohorts of workers in the nuclear industry in France, the UK, and the US included in a major update to the International Nuclear Workers Study (INWORKS).

Participants 309 932 workers with individual monitoring data for external exposure to ionising radiation and a total follow-up of 10.7 million person years.

Main outcome measures Estimates of excess relative rate per gray (Gy) of radiation dose for mortality from cancer.

Results The study included 103 553 deaths, of which 28 089 were due to solid cancers. The estimated rate of mortality due to solid cancer increased with cumulative dose by 52% (90% confidence interval 27% to 77%) per Gy, lagged by 10 years. Restricting the analysis to the low cumulative dose range (0-100 mGy) approximately doubled the estimate of association (and increased the width of its confidence interval), as did restricting the analysis to workers hired in the more recent years of operations when estimates of occupational external penetrating radiation dose were recorded more accurately. Exclusion of deaths from lung cancer and pleural cancer had a modest effect on the estimated magnitude of association, providing indirect evidence that the association was not substantially confounded by smoking or occupational exposure to asbestos.

Conclusions This major update to INWORKS provides a direct estimate of the association between protracted low dose exposure to ionising radiation and solid cancer mortality based on some of the world’s most informative cohorts of radiation workers. The summary estimate of excess relative rate solid cancer mortality per Gy is larger than estimates currently informing radiation protection, and some evidence suggests a steeper slope for the dose-response association in the low dose range than over the full dose range. These results can help to strengthen radiation protection, especially for low dose exposures that are of primary interest in contemporary medical, occupational, and environmental settings.

For reasons of ethics and permissions from different agencies, the data are maintained at the International Agency for Research on Cancer (Lyon, France) and cannot be made available outside of the agency.

Related Keywords

United Kingdom , Japan , Idaho , United States , France , British , French , Japanese , Robertd Daniels , Klervi Leuraud , Lenergie Atomique , Isabelle Thierry , Davidb Richardson , Dominique Laurier , Maryk Schubauer Berigan , Stephen Bertke , Monika Moissonnier , Michael Gillies , Ausrele Kesminiene , Richard Haylock , Kaitlin Kelly Reif , International Agency For Research On Cancer , International Collaborative Study Of Cancer Risk , United Nations Scientific Committee , British Nuclear Fuels , United Kingdom Health Security Agency , Us National Institute For Occupational Safety , Portsmouth Naval Shipyard , National Registry For Radiation Workers , International Nuclear Workers Study , Atomic Energy Authority , United Kingdom Atomic Energy Authority , Nuclear Industry , Oak Ridge National Laboratory , Idaho National Laboratory , Us National Cancer Institute , British Energy Generation , Ministry Of Defence , Atomic Energy Commission , International Commission On Radiological Protection , United Kingdom National Registry For Radiation Workers , National Council On Radiation Protection , Us Department Of Energy Hanford , International Collaborative Study , Cancer Risk , Radiation Workers , United Kingdom National Registry , Atomic Weapons Establishment , Magnox Electric , Savannah River , Portsmouth Naval , National Registry , Naval Shipyard , Cancer Institute , French Alternative Energies , Occupational Safety , French Institut De Radioprotection , International Agency , International Commission , Radiological Protection , National Council , Radiation Protection , Atomic Radiation , Open Access , Creative Commons Attribution Non Commercial ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.